Related Experiment Video
Updated: Oct 14, 2025

11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
39.1K
Risankizumab-induced paradoxical pustular psoriasis
O McFeely1, E Pender1, L Victory1
1Department of Dermatology, Mater Misericordiae University Hospital, Dublin, Ireland.
Clinical and Experimental Dermatology
|November 8, 2021
Abstract:
A 45-year-old white woman established on risankizumab self-presented to our service with pustular psoriasis affecting 60% of her body surface area. No history of pustular psoriasis was described in the 22 years that she had been diagnosed with psoriasis. This, to our knowledge, is the first case of paradoxical pustular psoriasis associated with risankizumab.

